Patent · US Active

Method for diagnosing esophageal cancer

US8945849B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 21, 2009
Grant dateFeb 3, 2015
Priority date
Expiry dateOct 12, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

This invention relates to a composition, kit, or DNA chip for use in diagnosis of esophageal cancer, which comprises a plurality of polynucleotides selected from the group consisting of polynucleotides whose expression levels are varied in esophageal cancer tissues obtained from esophageal cancer patients when compared with cancer-free esophageal tissues obtained from esophageal cancer patients, mutants thereof, and fragments thereof, and to a method for detecting esophageal cancer using the composition, kit, or DNA chip.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.